Protective efficacy of the nose gargle for the common cold symptom

Protective efficacy of the nose gargle for the common cold symptom - Protective efficacy of the nose gargle for the common cold symptom

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043196

Enrollment

Registered

2021-01-31

Start date

2021-01-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

common cold symptom

Interventions

For three months, they do a nose gargle in 120 ml of 0.9% saline once a day For three months, they do not a nose gargle

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The voluntary participants to this study among the staffs and the Institute of associate nursing students of the Self Defense Forces Sendai Hospital in 2021 years.

Exclusion criteria

Exclusion criteria: The patients who has an upper respiratory tract disease such as acute otitis media, allergic rhinitis, sinusitis, pharyngitis, pneumonia

Design outcomes

Primary

Measure	Time frame
three months later nose gargle start The number of patients that had a cold	—

Countries

Japan

Contacts

Public ContactTsugumi Fukunaga

Self-Defense Forces Sendai Hospital clinical department

pokethrush@yahoo.co.jp08020922779

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026